Modulation of TLR 3, 7 and 8 Expressions in HCV Genotype 3 Infected Individuals: Potential Correlations of Pathogenesis and Spontaneous Clearance

<div class="floats-full-page floats-full-page-other"><h2>Table 2</h2><div class="floats-full-page-caption">Primers used for SYBR Green PCR based amplification of TLRs in this study.</div><div class="floats-full-page-content"><table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr /></td></tr><tr class="thead"><td align="left">Toll receptors</td><td align="left">Primers</td><td align="left">Sequence</td><td align="left">NCBI accession reference number</td><td align="left">Start site</td><td align="left">Stop site</td><td align="left">Product size (bp)</td></tr><tr><td class="thead-hr" colspan="7"><hr /></td></tr><tr><td align="left" rowspan="2">TLR 3</td><td align="left">Forward</td><td align="left">5′-GTG CCA GAA ACT TCC CAT GT-3′</td><td align="left" rowspan="2">NM_003265.2</td><td align="left">383</td><td align="left">402</td><td align="left" rowspan="2">231</td></tr><tr><td align="left">Reverse</td><td align="left">5′-TCC AGC TGA ACC TGA GTT CC-3′</td><td align="left">594</td><td align="left">613</td></tr><tr><td align="center" colspan="7"><hr /></td></tr><tr><td align="left" rowspan="2">TLR 7</td><td align="left">Forward</td><td align="left">5′-AAT GTC ACA GCC GTC CCT AC-3′</td><td align="left" rowspan="2">NM_016562.3</td><td align="left">782</td><td align="left">801</td><td align="left" rowspan="2">223</td></tr><tr><td align="left">Reverse</td><td align="left">5′-GCG CAT CAA AAG CAT TTA CA-3′</td><td align="left">985</td><td align="left">1004</td></tr><tr><td align="center" colspan="7"><hr /></td></tr><tr><td align="left" rowspan="2">TLR 8</td><td align="left">Forward</td><td align="left">5′-TGT GAT GGT GGT GCT TCA AT-3′</td><td align="left" rowspan="2">XM_005274543.2</td><td align="left">1028</td><td align="left">1047</td><td align="left" rowspan="2">187</td></tr><tr><td align="left">Reverse</td><td align="left">5′-ATG CCC CAG AGG CTA TTT CT-3′</td><td align="left">1214</td><td align="left">1195</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr" /></td></tr></table></td></tr><tr class="table-fn"><td>Binding site refers to the site where polymerase chain reaction (PCR) primer binds to prime duplication of a complement to the existing complementary DNA (cDNA) sequence of the mRNA; bp: base pair.<br /></td></tr></table></div></div>

Table 2 | Modulation of TLR 3, 7 and 8 Expressions in HCV Genotype 3 Infected Individuals: Potential Correlations of Pathogenesis and Spontaneous Clearance

title

Table 2: Modulation of TLR 3, 7 and 8 Expressions in HCV Genotype 3 Infected Individuals: Potential Correlations of Pathogenesis and Spontaneous Clearance

description

Table 2

About this journal

<p><em>BioMed Research International</em> publishes original research articles, review articles, and clinical studies covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.</p>


Journal profile

Meet the editorial board

<p><em>BioMed Research International</em> maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.